Douglas C Wallace

Douglas C Wallace, PhD, serves as Professor of Pediatrics in the Division of Human Genetics at Children's Hospital of Philadelphia (CHOP), affiliated with the University of Pennsylvania. He directs The Center for Mitochondrial and Epigenomic Medicine at CHOP's Research Institute and holds membership in the Cell and Molecular Biology Graduate Group.

His educational credentials include:

• B.S. in Genetics and Developmental Biology from Cornell University (1968)
• M. Phil. in Microbiology and Human Genetics from Yale University (1972)
• PhD in Microbiology and Human Genetics from Yale University (1975)
• NIH Postdoctoral Fellowship at Yale University (1975-1976)

Dr. Wallace maintains board certification from the American Board of Medical Genetics in Ph.D. Medical Genetics (1989) and Clinical Molecular Genetics (1993). His research centers on mitochondrial and epigenomic medicine, investigating how mitochondrial DNA variations impact human diseases through mechanisms spanning genetic, metabolic, and immune pathways. Current work examines mitochondrial dysfunction in sepsis, cancer, exercise physiology, and viral infections like SARS-CoV-2.

Analysis of his 2021-2022 publications reveals consistent focus on mitochondrial genetics across diverse disease contexts. Key trends include development of advanced diagnostic tools for mitochondrial disorders, exploration of immunometabolic interactions in critical illness, and investigation of viral-mitochondrial crosstalk. His work demonstrates strong translational emphasis with clinical applications in pediatrics and genetics.

The available documentation does not specify grant funding details or student advising activities. Dr. Wallace leads The Center for Mitochondrial and Epigenomic Medicine at CHOP's Colket Translational Research Building, where his team integrates genomic analysis with clinical research to advance mitochondrial disease diagnostics and therapeutics.